SHARE
Dna And Gene Chip Market

DNA and Gene Chip Market Forecasts to 2028 – Global Analysis By Type (oDNA, cDNA), Product (Instrumentation, Consumables), Application (Agrigenomics, Genomics, SNP Analysis) and By Geography

4.1 (63 reviews)
Published: December 2021 ID: SMRC21208
4.1 (63 reviews)
Published: December 2021 ID: SMRC21208

This report covers the impact of COVID-19 on this global market
Loading...

According to Stratistics MRC, the Global DNA and Gene Chip Market is accounted for $5.84 billion in 2020 and is expected to reach $15.97 billion by 2028 growing at a CAGR of 13.4% during the forecast period. The growth of personalized medicines, robotics and fabrication methods for microarrays and rapid growth of microarray technology in computational capabilities are driving the market growth. However, lack of technical skilled employees is hampering the growth of the market.

DNA gene chips are small chips that are engrafted with DNA molecules. A DNA gene chip size resembles the size of a postage stamp. The DNA gene chip enables medical researchers to measure the expression level of thousands of gene simultaneously. DNA gene chips technology is used to analyze the gene expression through information contained in a genome.

Based on the end user, the academic and government research institutes segment is going to have lucrative growth during the forecast period as they use the microarrays to discover newer unconventional fields in which informatics can be used to improve the procedures due to which the highest growth rates have been registered in this particular field. By geography, North America is going to have high growth during the forecast period due to the developing healthcare infrastructure owing to presence of advanced informatics infrastructure, rise in incentives and well-established players in this region.

Some of the key players profiled in the DNA and Gene Chip Market include Thermo Fisher Scientific, Inc, Greiner Bio One International GmbH, Perkin Elmer, Inc., Microarrays Inc, Illumina, Inc, Merck KGaA, Biometrix Technology Inc, Shanghai Biochip Co Ltd, Savyon Diagnostics and Agilent Technologies.

Report Coverage

Details

Published Year:

2021

Estimated Market Size in 2020:

USD 5.84 billion

Estimated Period:

2020

Compound Annual Growth Rate (CAGR)  from 2020 to 2028:

13.4%

Predicted 2028 Value:

USD 15.97 billion

Forecast Years:

2021-2028

Tables, Graphs & Figures

124

Chapters Covered:

Type, Product, Application, End User and Region

Core Drivers and Opportunities:

  • The growth of personalized medicines
  • Robotics and fabrication methods for microarrays
  • Rapid growth of microarray technology in computational capabilities

Restraining Factors & Market Threats:

  • Lack of technical skilled employees
  • Substitute technologies


Types Covered:
• Oligonucleotide DNA Microarrays (oDNA) 
• Complementary DNA Microarrays (cDNA)
 
Products Covered:
• Instrumentation 
• Consumables 

Applications  Covered:
• Gene Expression  
• Proteomics 
• Genotyping 
• Single Nucleotide Polymorphism (SNP) Analysis 
• Cancer Diagnosis & Treatment 
• Drug Discovery/Agricultural Biotechnology 
• Agrigenomics 
• Genomics  

End Users Covered: 
• Academic & Government Research Institutes 
• Biotechnology and Pharmaceutical Companies 
• Hospitals and Diagnostics Centers 

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan       
o China       
o India       
o Australia 
o New Zealand
o South Korea
o Rest of Asia Pacific   
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2019, 2020, 2021, 2025 and 2028
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Key Questions Answered In The Report

The Global DNA and Gene Chip Market is majorly driven by the growth of personalized medicines, robotics and fabrication methods for microarrays and rapid growth of microarray technology in computational capabilities.

The academic and government research institutes segment is growing at a highest CAGR as they use the microarrays to discover newer unconventional fields in which informatics can be used to improve the procedures.

North America dominated with a significant market share due to the developing healthcare infrastructure owing to presence of advanced informatics infrastructure, rise in incentives and well-established players in this region.

Asia Pacific market is growing at a highest CAGR attributed to research initiatives in countries like China and India in the region. Medical tourism, sustainable agricultural yield requirement due to high population are responsible factors for regional market growth.

Key players in DNA and Gene Chip Market include Thermo Fisher Scientific, Inc, Greiner Bio One International GmbH, Perkin Elmer, Inc., Microarrays Inc, Illumina, Inc, Merck KGaA, Biometrix Technology Inc, Shanghai Biochip Co Ltd, Savyon Diagnostics and Agilent Technologies.

Select License Type

NEW YEAR SALE
Allows one person to have access to the ordered product.The ordered product cannot be distributed to anyone else.
Allows the ordered product to be shared among a maximum of 5 people within your organisation.
Allows the product to be shared among all employees of your organisation at one particular location.
Allows the product to be shared among all employees of your organisation regardless of their geographical location.

WHY CHOOSE US ?

Assured Quality

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Free Customization

Adding more values to your product of interest.

Safe and Secure Access

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials